Ascentage Pharma Group International (6855.HK)

HKD 48.6

(-1.02%)

Total Liabilities Summary of Ascentage Pharma Group International

  • Ascentage Pharma Group International's latest annual total liabilities in 2023 was 2.42 Billion CNY , up 0.34% from previous year.
  • Ascentage Pharma Group International's latest quarterly total liabilities in 2024 Q2 was 2.33 Billion CNY , down 0.0% from previous quarter.
  • Ascentage Pharma Group International reported annual total liabilities of 2.42 Billion CNY in 2022, up 42.0% from previous year.
  • Ascentage Pharma Group International reported annual total liabilities of 1.7 Billion CNY in 2021, up 92.82% from previous year.
  • Ascentage Pharma Group International reported quarterly total liabilities of 2.42 Billion CNY for 2023 Q4, down 0.0% from previous quarter.
  • Ascentage Pharma Group International reported quarterly total liabilities of 2.42 Billion CNY for 2023 FY, up 0.34% from previous quarter.

Annual Total Liabilities Chart of Ascentage Pharma Group International (2023 - 2016)

Historical Annual Total Liabilities of Ascentage Pharma Group International (2023 - 2016)

Year Total Liabilities Total Liabilities Growth
2023 2.42 Billion CNY 0.34%
2022 2.42 Billion CNY 42.0%
2021 1.7 Billion CNY 92.82%
2020 884.41 Million CNY 181.15%
2019 314.57 Million CNY -85.96%
2018 2.24 Billion CNY 214.1%
2017 713.46 Million CNY 17.36%
2016 607.94 Million CNY 0.0%

Peer Total Liabilities Comparison of Ascentage Pharma Group International

Name Total Liabilities Total Liabilities Difference
Uni-Bio Science Group Limited 152.81 Million HKD -1489.97%
CK Life Sciences Int'l., (Holdings) Inc. 7.05 Billion HKD 65.575%